PMID: 9445494Jan 31, 1998Paper

A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team

Pediatrics
M W KlineN Hutcheon

Abstract

To compare the safety and tolerance of stavudine (d4T) versus zidovudine (ZDV, AZT) in symptomatic human immunodeficiency virus-infected children 3 months to 6 years of age. In an initially double-blind trial, 212 evaluable human immunodeficiency virus-infected children who had received no more than 6 weeks of previous antiretroviral therapy were randomized to receive either d4T (1 mg/kg orally every 12 hours, maximum 40 mg orally every 12 hours) or zidovudine (180 mg/m2 orally every 6 hours, maximum 200 mg orally every 6 hours). The study was unblinded after a median follow-up period of 6.3 months; median follow-up at study closure was 17.3 months. Tolerance, safety, disease progression, and immunologic responses were evaluated. The patient population was young (median age, 1.2 years; range, 0.3 to 6.4 years), with a median baseline CD4+ lymphocyte count of 965 cells/microL (range, 18 to 4238 cells/microL). Neutropenia < 400/microL occurred significantly more commonly among zidovudine recipients (1-year event rates of 20% both up to the time of unblinding and throughout the entire study) than among children receiving d4T (1-year event rates of 5% up to the time of unblinding and 6% throughout the entire study). In exploratory ...Continue Reading

Citations

Jan 1, 1970·Calcified Tissue Research·G Nichols
Mar 4, 2000·Pediatric Clinics of North America·P E Palumbo
Nov 25, 2003·Lancet·David Dunn, UNKNOWN HIV Paediatric Prognostic Markers Collaborative Study Group
May 25, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J S MontanerR Hogg
Aug 26, 1998·AIDS·V J CareyR E McKinney
Feb 15, 2001·The Pediatric Infectious Disease Journal·W M DanknerUNKNOWN Pediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327
Mar 31, 2010·The Pediatric Infectious Disease Journal·Gabriela MarónPatricia M Flynn
Jun 2, 2004·Paediatric Drugs·Jennifer Handforth, Mike Sharland
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Takehisa IkedaJames M Oleske
Nov 1, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Daniel Avi LembergJohn B Ziegler
Jun 29, 2004·Nuclear Medicine and Biology·Eli LivniAlan J Fischman
Feb 18, 2003·Molecular and Cellular Biology·Jinah ChoiJing-hsiung Ou
May 24, 2017·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·A K NkwataA E Ezeamama
Apr 25, 2019·Journal of Thyroid Research·Adeseye AkinseteEdamisan Temiye
Feb 3, 2006·Pediatrics·Grace M LeeUNKNOWN Pediatric AIDS Clinical Trials Group Protocol 219C Team

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.